- What Each Firm Does
- Side-by-Side Comparison
- When to Pick Each Firm
- Proof Points
- FAQs
- Make the Right Call Before Your Next Milestone
If you are a seed-to-Series B biotech or SaaS founder comparing fractional CFO options before a fundraise, board meeting, or tax deadline, this comparison is for you. Both K-38 Consulting and Burkland Associates offer fractional CFO services for life sciences and SaaS companies — but they are built for different situations, and choosing the wrong one at the wrong stage has real consequences.
Here is what each firm actually does, where they diverge, and which one fits your specific situation.
What Each Firm Does
K-38 Consulting
K-38 Consulting is a Raleigh, NC-based financial consulting firm operating on a remote-first model. Rather than functioning as a bolt-on service, K-38 embeds fractional and outsourced CFO talent alongside dedicated controller services directly into a company's finance function.
The firm serves eight named verticals: biotech, SaaS, healthcare, e-commerce, law, real estate, CPG, and construction. That breadth matters — it means K-38 works with both venture-backed startups and non-venture midsize businesses operating in regulated industries. Specialized services include R&D tax credits, cost segregation, and accounting automation, all scoped under a single engagement rather than referred out to third parties.
Pricing is engagement-specific. K-38 does not publish fixed tiers; a free quote scopes the engagement based on your stage, complexity, and what you actually need.
Burkland Associates
Burkland Associates is a San Francisco-based firm that exclusively serves venture-backed startups from pre-seed through Series C. The firm has worked with more than 800 venture-backed clients, supported companies that raised over $25 billion in total funding, and processes more than $25 million in R&D credits annually. Those are Burkland's own published figures — presented here as competitive context.
Burkland offers fractional CFO, accounting, tax, and HR services, with a dedicated biotech and healthcare practice and VC-network experience built in. Pricing is published on their site, with CFO tiers starting at $1,600 per month (Starter), $2,500 per month (Core), and $4,200 per month (Advanced).
Side-by-Side Comparison
| Feature | K-38 Consulting | Burkland Associates |
|---|---|---|
| Fractional CFO | ✓ Engagement-specific quote | ✓ Tiers from $1,600/mo (Starter), $2,500/mo (Core), $4,200/mo (Advanced) — see burklandassociates.com/pricing |
| Outsourced CFO | ✓ Dedicated service line | Bundled into same fractional CFO tiers; not sold separately |
| Controller Services | ✓ Dedicated service line | Included only in separate bookkeeping/accounting tiers (Advanced accounting tier includes a dedicated controller) — not part of CFO tiers |
| R&D Tax Credit | ✓ Up to $250,000+ for qualifying businesses; quote-based | ✓ Service fee typically $4,000–$7,000 (Burkland's fee for the service, not the credit value) — see burklandassociates.com/pricing |
| Cost Segregation | ✓ Included as a service line | Not listed as a service |
| Biotech/Healthcare Vertical | ✓ Named vertical | ✓ Dedicated biotech and healthcare practice — burklandassociates.com/who-we-work-with/healthcare |
| Fundraising and Board Support | Scoped per engagement; confirm inclusion when requesting a quote | ✓ Included in Core and Advanced CFO tiers (fundraising KPIs, board support, cash forecasting, scenario planning) — see burklandassociates.com/pricing |
| Business Types Served | Venture-backed startups AND non-venture midsize biotech/healthcare businesses | Exclusively venture-backed startups, pre-seed through Series C |
When to Pick Each Firm
Choose K-38 Consulting if:
You need R&D tax credits, cost segregation, and CFO strategy bundled under one firm rather than managed across separate vendors. You are not venture-backed — or you are a bootstrapped or growth-stage biotech or healthcare business that does not fit the VC-exclusive model. You want a Raleigh-based team with regional relationship continuity and a hands-on controller working alongside your CFO function.
Choose Burkland Associates if:
You are a venture-backed biotech startup that wants published tiered pricing and a firm with deep VC-network experience. You need bundled HR support alongside CFO work. You want a dedicated biotech and healthcare practice with a track record measured in hundreds of VC-backed clients and billions in client funding raised.
Neither choice is wrong. The question is whether your business fits the model the firm was built for.
Proof Points
Burkland's scale is publicly documented: 800+ venture-backed clients, $25 billion-plus in client funding raised, and $25 million-plus in annual R&D credits processed. For a VC-backed Series A or B biotech that wants a firm with proven VC-ecosystem relationships, those numbers signal relevant depth.
K-38 does not publish equivalent client-volume statistics. What the firm offers instead is a broader service bundle — CFO, controller, R&D credits, and cost segregation under one engagement — and the flexibility to serve businesses that fall outside the venture-backed model.
The broader market supports both firms. According to the Deloitte CFO Signals Survey, 68% of companies under $50 million in revenue used outsourced or fractional finance leadership in 2025, up from 41% in 2022. That shift reflects a structural change in how growing companies build their finance function — not a temporary workaround.
For biotech and healthcare businesses specifically, the decision often comes down to one question: are you building toward a VC exit, or building a durable, capital-efficient business? The answer shapes which model fits.
FAQs
How much does a fractional CFO cost for a Series A biotech?
Burkland Associates publishes tiered pricing on their site. CFO tiers start at $1,600 per month (Starter), $2,500 per month (Core), and $4,200 per month (Advanced), with scope differences at each level. K-38 Consulting does not publish fixed tiers. Fractional CFO retainers are scoped per engagement through a free quote, with retainers generally in the $5,000 to $15,000-plus per month range depending on your stage, complexity, and the services included.
Does K-38 handle R&D tax credits for biotech startups?
Yes. R&D tax credits are a core K-38 service line — not an add-on referred to a third party. For qualifying businesses, K-38 has identified $250,000 or more in credits through this service. It is delivered alongside CFO and controller work under the same engagement, which means the strategy and the tax filing stay coordinated rather than siloed.
Can one firm handle CFO, tax strategy, and controller work?
K-38 bundles all three — fractional CFO, dedicated controller services, R&D tax credits, and cost segregation — under a single engagement. Burkland's CFO tiers bundle fundraising support, board prep, cash forecasting, and scenario planning, which is strong for VC-stage companies. Controller-level depth and R&D credit filing at Burkland are offered through separate accounting tiers and add-on services rather than as part of one integrated package. If you want a single firm managing the full stack from financial reporting to tax optimization, K-38's model is structured for that.
Make the Right Call Before Your Next Milestone
A fundraise, board meeting, or tax deadline is not the time to discover your finance function has gaps. Whether you need a fractional CFO who can speak to investors, a controller keeping your books audit-ready, or a team that can identify R&D credits and cost segregation opportunities before year-end — the right firm is the one built for your specific situation.
To find out how K-38 Consulting structures engagements for biotech and healthcare businesses, request a free quote at k38consulting.com.
Written by Dallas Alford IV, CPA
Founder & CEO, K-38 Consulting, LLC | Former PwC & KPMG Senior Manager
Dallas Alford IV is a licensed Certified Public Accountant (CPA) with over 20 years of corporate accounting and fractional CFO experience. He previously spent over a decade leading audit, SOX compliance, and financial advisory teams at PricewaterhouseCoopers (PwC) and KPMG. He holds a Master of Science in Accounting from the University of North Carolina Wilmington.
View Full Background & Career Timeline →




